Natalia Issaeva Selected Research

Natalia Issaeva Research Topics

Disease

26	Neoplasms (Cancer) 10/2022 - 02/2002
8	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2017
8	Head and Neck Neoplasms (Head and Neck Cancer) 12/2020 - 05/2014
3	Carcinogenesis 01/2017 - 10/2014
2	Neuroblastoma 01/2021 - 11/2015
2	Oropharyngeal Neoplasms 01/2018 - 05/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 05/2014
1	Genomic Instability 01/2021
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Hypopharyngeal Neoplasms 01/2016
1	Avian Reticuloendotheliosis 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Papillomavirus Infections 10/2014
1	Inflammation (Inflammations) 08/2012
1	Melanoma (Melanoma, Malignant) 01/2011
1	Colonic Neoplasms (Colon Cancer) 01/2007
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2006

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 11/2006
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2002
3	TNF Receptor-Associated Factor 3IBA 01/2022 - 01/2017
3	protoporphyrin IXIBA 01/2022 - 01/2007
3	Biological ProductsIBA 10/2018 - 05/2014
2	NF-kappa B (NF-kB)IBA 01/2022 - 01/2016
2	Drug CombinationsIBA 01/2021 - 07/2020
2	CBLC137IBA 01/2021 - 11/2015
2	ChromatinIBA 01/2021 - 11/2015
2	Azacitidine (5 Azacytidine)FDA Link 12/2020 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2018
2	PlatinumIBA 01/2019 - 08/2010
2	maleimideIBA 12/2017 - 08/2005
2	Phosphotransferases (Kinase)IBA 06/2016 - 11/2006
2	Pharmaceutical PreparationsIBA 01/2011 - 12/2004
2	Tumor Suppressor Protein p53IBA 01/2007 - 02/2002
1	Nucleosomes (Nucleosome)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	PanobinostatIBA 01/2021
1	adavosertibIBA 01/2019
1	MLN 8237IBA 01/2019
1	Aurora Kinase AIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	InterferonsIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 12/2017
1	Complement System Proteins (Complement)IBA 12/2017
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2017
1	RoscovitineIBA 06/2016
1	Adenosine Triphosphate (ATP)IBA 06/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2016
1	AndrogensIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Bile Acids and Salts (Bile Acids)IBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Wnt-5a ProteinIBA 01/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2016
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	ARTIK-52IBA 01/2016
1	Histone ChaperonesIBA 11/2015
1	Oncogene Proteins (Oncogene Protein)IBA 10/2014
1	RNA (Ribonucleic Acid)IBA 10/2014
1	AsbestosIBA 08/2012
1	Caspase 9IBA 01/2011
1	eprenetapoptIBA 01/2011
1	IntegrinsIBA 01/2011
1	CollagenIBA 01/2011
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2010
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2010
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2010
1	Cisplatin (Platino)FDA LinkGeneric 08/2010
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2010
1	Thioguanine (Tioguanine)FDA Link 08/2010
1	thiazolyl blueIBA 01/2007
1	Photosensitizing Agents (Photosensitizers)IBA 01/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2007
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2007
1	fragile histidine triad proteinIBA 01/2007
1	Histidine (L-Histidine)FDA Link 01/2007
1	Tetracycline (Achromycin)FDA LinkGeneric 08/2005
1	1-(propoxymethyl)maleimideIBA 08/2005
1	NSC 652287IBA 12/2004
1	Fluorescein (Funduscein)FDA LinkGeneric 11/2003
1	Peptides (Polypeptides)IBA 11/2003
1	fluoresceinyl- arginyl- glutamyl- aspartyl- glutamyl- aspartyl- glutamyl- isoleucyl- glutamyl- tryptophanIBA 11/2003
1	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 12/2002
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2002
1	UbiquitinIBA 02/2002

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2016
5	Drug Therapy (Chemotherapy) 06/2016 - 08/2005
2	Photochemotherapy (Photodynamic Therapy) 01/2007 - 01/2007
2	Radiotherapy 01/2007 - 08/2005
1	Transplantation 01/2021
1	Immunotherapy 01/2021
1	Combined Modality Therapy 01/2021
1	Lasers (Laser) 01/2007